TABLE 10.1 (continued)
Combined Impact of Toxicity, Mobility, Persistence, and Bioaccumulation
(Effective Toxicity Factor, ETF)
TF (Doses/
ETF (Doses/
Chemical Name
Capita-lb)
MF
PF
BAF
Capita-lb)
2-Chloro-1,1,1,29.87E–03
0.51005
4.33E–04
4.33E–04
4.33E–04
tetrafluoroethane
2-Chloro-1,1,1-trifluoroethane
0.00E+00
0.04798
0.00E+00
0.00E+00
0.00E+00
2-Chloroacetophenone
1.02E–02
0.002
2.05E–05
—
—
2-Mercaptobenzothiazole
8.13E–03
0.00549
1.53E–06
1.53E–06
1.53E–06
2-Methyllactonitrile
2.45E–05
0.51622
1.56E–07
1.56E–07
1.56E–07
2-Methylpyridine
8.13E–03
0.55130
7.43E–05
7.43E–05
7.43E–05
2-Nitrophenol
1.28E–02
0.03205
7.25E–06
7.25E–06
7.25E–06
2-Nitropropane
8.28E–01
0.13059
1.79E–03
1.79E–03
1.79E–03
2-Phenylphenol
1.10E–04
0.01404
1.42E–07
1.42E–07
1.42E–07
3,3-Dichloro-1,1,1,2,2—
0.00201
—
—
—
pentafluoropropane
3,3′-Dichlorobenzidine
1.30E–01
0.02997
1.49E–03
1.49E–03
1.49E–03
3,3′-Dichlorobenzidine
4.18E–03
0.02997
4.78E–05
4.78E–05
4.78E–05
dihydrochloride
3,3′-Dichlorobenzidine sulfate
1.30E–01
0.02997
1.49E–03
1.49E–03
1.49E–03
3,3′-Dimethoxybenzidine
8.13E–04
0.00389
8.34E–08
8.34E–08
8.34E–08
3,3′-Dimethoxybenzidine
4.06E–03
0.01347
8.88E–07
8.88E–07
8.88E–07
dihydrochloride
3-Chloro-2-methyl-1-propene
2.47E–03
0.20163
1.83E–05
1.83E–05
1.83E–05
3-Iodo-2-propynyl
5.81E–06
0.00565
1.17E–09
1.17E–09
1.17E–09
butylcarbamate
4,4′-Diaminodiphenyl ether
1.16E–03
0.01184
2.56E–07
2.56E–07
2.56E–07
4,4′-Isopropylidenediphenol
1.16E–06
0.00549
7.27E–10
7.27E–10
7.27E–10
4,4′-Methylenebis(21.38E–01
0.00188
1.92E–04
1.92E–04
1.92E–04
chloroaniline)
4,4′-Methylenebis(N,N6.66E–03
0.002
1.33E–05
—
—
dimethyl)benzenamine
4,4′-Methylenedianiline
2.34E–01
0.04707
2.40E–04
2.40E–04
2.40E–04
4,6-Dinitro-O-cresol
5.81E–04
0.00720
1.62E–07
1.62E–07
1.62E–07
4-Aminoazobenzene
1.09E–03
0.00284
7.65E–07
7.65E–07
7.65E–07
4-Aminobiphenyl
3.06E+00
0.00762
2.37E–03
2.37E–03
2.37E–03
4-Dimethylaminoazobenzene
6.66E–01
0.00026
4.08E–04
4.08E–04
4.08E–04
4-Nitrophenol
2.90E–05
0.05397
1.25E–07
1.25E–07
1.25E–07
5-Nitro-O-anisidine
7.14E–03
0.002
1.43E–05
—
—
5-Nitro-O-toluidine
1.92E–03
0.03127
1.71E–06
1.71E–06
1.71E–06
Abamectin
1.16E–03
0.00113
2.75E–06
2.75E–06
2.75E–06
Acephate
5.20E–04
0.45224
3.62E–06
3.62E–06
3.62E–06
Acetaldehyde
7.09E–04
0.99342
6.89E–06
6.89E–06
6.89E–06
Acetamide
6.14E–05
0.50602
3.10E–07
3.10E–07
3.10E–07
continued
141
Developing Effective Toxicity Factors
Combined Impact of Toxicity, Mobility, Persistence, and Bioaccumulation
(Effective Toxicity Factor, ETF)
TF (Doses/
ETF (Doses/
Chemical Name
Capita-lb)
MF
PF
BAF
Capita-lb)
2-Chloro-1,1,1,29.87E–03
0.51005
4.33E–04
4.33E–04
4.33E–04
tetrafluoroethane
2-Chloro-1,1,1-trifluoroethane
0.00E+00
0.04798
0.00E+00
0.00E+00
0.00E+00
2-Chloroacetophenone
1.02E–02
0.002
2.05E–05
—
—
2-Mercaptobenzothiazole
8.13E–03
0.00549
1.53E–06
1.53E–06
1.53E–06
2-Methyllactonitrile
2.45E–05
0.51622
1.56E–07
1.56E–07
1.56E–07
2-Methylpyridine
8.13E–03
0.55130
7.43E–05
7.43E–05
7.43E–05
2-Nitrophenol
1.28E–02
0.03205
7.25E–06
7.25E–06
7.25E–06
2-Nitropropane
8.28E–01
0.13059
1.79E–03
1.79E–03
1.79E–03
2-Phenylphenol
1.10E–04
0.01404
1.42E–07
1.42E–07
1.42E–07
3,3-Dichloro-1,1,1,2,2—
0.00201
—
—
—
pentafluoropropane
3,3′-Dichlorobenzidine
1.30E–01
0.02997
1.49E–03
1.49E–03
1.49E–03
3,3′-Dichlorobenzidine
4.18E–03
0.02997
4.78E–05
4.78E–05
4.78E–05
dihydrochloride
3,3′-Dichlorobenzidine sulfate
1.30E–01
0.02997
1.49E–03
1.49E–03
1.49E–03
3,3′-Dimethoxybenzidine
8.13E–04
0.00389
8.34E–08
8.34E–08
8.34E–08
3,3′-Dimethoxybenzidine
4.06E–03
0.01347
8.88E–07
8.88E–07
8.88E–07
dihydrochloride
3-Chloro-2-methyl-1-propene
2.47E–03
0.20163
1.83E–05
1.83E–05
1.83E–05
3-Iodo-2-propynyl
5.81E–06
0.00565
1.17E–09
1.17E–09
1.17E–09
butylcarbamate
4,4′-Diaminodiphenyl ether
1.16E–03
0.01184
2.56E–07
2.56E–07
2.56E–07
4,4′-Isopropylidenediphenol
1.16E–06
0.00549
7.27E–10
7.27E–10
7.27E–10
4,4′-Methylenebis(21.38E–01
0.00188
1.92E–04
1.92E–04
1.92E–04
chloroaniline)
4,4′-Methylenebis(N,N6.66E–03
0.002
1.33E–05
—
—
dimethyl)benzenamine
4,4′-Methylenedianiline
2.34E–01
0.04707
2.40E–04
2.40E–04
2.40E–04
4,6-Dinitro-O-cresol
5.81E–04
0.00720
1.62E–07
1.62E–07
1.62E–07
4-Aminoazobenzene
1.09E–03
0.00284
7.65E–07
7.65E–07
7.65E–07
4-Aminobiphenyl
3.06E+00
0.00762
2.37E–03
2.37E–03
2.37E–03
4-Dimethylaminoazobenzene
6.66E–01
0.00026
4.08E–04
4.08E–04
4.08E–04
4-Nitrophenol
2.90E–05
0.05397
1.25E–07
1.25E–07
1.25E–07
5-Nitro-O-anisidine
7.14E–03
0.002
1.43E–05
—
—
5-Nitro-O-toluidine
1.92E–03
0.03127
1.71E–06
1.71E–06
1.71E–06
Abamectin
1.16E–03
0.00113
2.75E–06
2.75E–06
2.75E–06
Acephate
5.20E–04
0.45224
3.62E–06
3.62E–06
3.62E–06
Acetaldehyde
7.09E–04
0.99342
6.89E–06
6.89E–06
6.89E–06
Acetamide
6.14E–05
0.50602
3.10E–07
3.10E–07
3.10E–07
continued
141
Developing Effective Toxicity Factors